ClinicalTrials.Veeva

Menu

Effect of High Flow Nasal Cannula Versus Continues Positive Airway Pressure in Adults With Obstructive Sleep Apnea

K

King Abdulaziz University

Status

Enrolling

Conditions

Sleep Apnea

Treatments

Device: High Flow Nasal Cannula (HFNC)
Device: Continuous Positive Airway Pressure (CPAP)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The participants whom undergo Polysomnography study (Sleep study) and are found to have mild, moderate or severe Obstructive Sleep Apnea (OSA) will have two consecutive titration nights. Randomly, they'll do (CPAP) titration followed by (HFNC) titration or vice versa. To explore the possibility of the CPAP not being superior to HFNC in reduction of sleep apnea events.

Full description

The participants undergo three nights in the Sleep Lab. In their first night they perpetrate Polysomnography study (Sleep study) and then classifies to have mild, moderate or severe Obstructive Sleep Apnea (OSA) or not. Those who are diagnosed with OSA, will undergo two consecutive titration nights. Randomly, they'll do (CPAP) titration followed by (HFNC) titration or vice versa. To explore the possibility of the CPAP not being superior to HFNC in reduction of sleep apnea events.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults patient aging above 18 years
  • Diagnosed with Obstructive Sleep Apnea (OSA) based on Polysomnography (PSG) ranging from mild to severe i.e. more than 5

Exclusion criteria

  • Patients with hypoventilation syndrome
  • Patients with chronic obstructive pulmonary disease
  • Patients who have unstable hemodynamic state, who experienced intolerance to HFNC or CPAP
  • Patients who are pregnant
  • Patients recently underwent surgery

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Participants diagnosed with Obstructive Sleep Apnea
Experimental group
Description:
The participants will sleep three nights at the sleep lab and undergo in their first night, Polysomnography (PSG). Then at random, some of them will do CPAP titration in the second night followed by HFNC titration in the third night. While others will do HFNC titration in the second night followed by CPAP titration in the third night
Treatment:
Device: High Flow Nasal Cannula (HFNC)
Device: Continuous Positive Airway Pressure (CPAP)

Trial contacts and locations

1

Loading...

Central trial contact

Siraj O Wali, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems